Narayana Hrudayalaya Limited (BOM:539551)
India · Delayed Price · Currency is INR | Market Cap | 349.96B -1.5% |
| Revenue (ttm) | 90.72B +59.6% |
| Net Income | 8.16B +3.9% |
| EPS | 40.19 +3.9% |
| Shares Out | n/a |
| PE Ratio | 42.88 |
| Forward PE | 29.20 |
| Dividend | 4.50 (0.26%) |
| Ex-Dividend Date | Jul 17, 2026 |
| Volume | 8,854 |
| Open | 1,713.00 |
| Previous Close | 1,716.55 |
| Day's Range | 1,692.05 - 1,733.20 |
| 52-Week Range | 1,564.25 - 2,094.30 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 2,238.42 (+29.91%) |
| Earnings Date | Oct 30, 2026 |
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, der... [Read more]
Financial Performance
In fiscal year 2026, Narayana Hrudayalaya's revenue was 78.96 billion, an increase of 44.01% compared to the previous year's 54.83 billion. Earnings were 8.06 billion, an increase of 1.95%.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for 539551 stock is "Strong Buy." The 12-month stock price target is ₹2,238, which is an increase of 29.91% from the latest price.
News
Top stocks to buy today: Stock recommendations for August 26, 2026 - check list
Stock market recommendations: Tata Steel, Max Healthcare Institute, and Narayana Hrudayalaya - these are the top stok picks from Mehul Kothari, DVP - Technical Research at Anand Rathi Shares for Augus...
Narayana Hrudayalaya Transcript: Q1 26/27
EBITDA margins expanded in India, driven by high-end procedures and clinic growth, while Cayman insurance losses narrowed and U.K. operations faced temporary setbacks from heatwave disruptions. Cash reserves will fund major projects, and margin improvement is expected as integration costs normalize.
Narayana Hrudayalaya Quarterly report: Q1 2027
Narayana Hrudayalaya has published its Q1 2027 quarterly earnings report on August 3, 2026.
Narayana Hrudayalaya Slides: Q1 2027
Narayana Hrudayalaya has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 3, 2026.
Narayana Hrudayalaya announces ₹4.50 per share dividend for FY 2025-26
Narayana Hrudayalaya has declared a dividend of ₹4.50 per equity share for the financial year ending March 31, 2026, subject to approval at the Annual General Meeting on August 14,…
Narayana Hrudayalaya Transcript: Q4 25/26
Margin expansion in India was driven by high-end procedures and payer mix, while U.K. integration is ongoing with cost synergies expected. Cayman insurance losses are being addressed through pricing and client rationalization, and clinics continue to act as key feeders for hospital growth.
Narayana Hrudayalaya Quarterly report: Q4 2026
Narayana Hrudayalaya has published its Q4 2026 quarterly earnings report on May 26, 2026.
Narayana Hrudayalaya Slides: Q4 2026
Narayana Hrudayalaya has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 26, 2026.
Narayana Hrudayalaya Annual report: Q4 2026
Narayana Hrudayalaya has published its Q4 2026 annual report on May 26, 2026.
Top stocks to buy today: Stock recommendations for May 13, 2026 - check list
Stock market recommendations: Mehul Kothari, DVP - Technical Research at Anand Rathi Shares has chosen Narayana Hrudayalaya, Coal India, and Hyundai Motor India as the top stocks for buying today, May...
Narayana Hrudayalaya Transcript: Q3 25/26
India delivered strong profit and margin expansion, led by transformation and high-end procedures, while UK and Cayman segments focus on operational improvements and market share gains. CapEx and expansion are funded by internal accruals and debt, with no equity raise planned.
Narayana Hrudayalaya Quarterly report: Q3 2026
Narayana Hrudayalaya has published its Q3 2026 quarterly earnings report on February 17, 2026.
Narayana Hrudayalaya Slides: Q3 2026
Narayana Hrudayalaya has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 17, 2026.
Stocks to buy: What's the outlook for Nifty for the week starting November 24? Check list of top stock recommendations
Stock market recommendations: Market expert Sudeep Shah highlights Narayana Hrudayalaya and Indigo as top stock picks. While Nifty nears highs, broader markets show weakness, signaling caution. Bank N...
Narayana Hrudayalaya Transcript: Q2 25/26
Q2 FY2026 delivered strong revenue and EBITDA growth, led by Cayman and India operations, with robust hospital margins and improving insurance performance. India saw 20% EBITDA growth, while the Cayman business posted 70% revenue growth year-over-year.
Narayana Hrudayalaya Quarterly report: Q2 2026
Narayana Hrudayalaya has published its Q2 2026 quarterly earnings report on November 17, 2025.
Narayana Hrudayalaya Slides: Q2 2026
Narayana Hrudayalaya has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 17, 2025.
Narayana Hrudayalaya shares jump nearly 5% after Q2 profit up 30%
Shares of Narayana Hrudayalaya surged nearly 5% to Rs 1,835 in early trade on Monday, November 17, after the healthcare...
Narayana Hrudayalaya Transcript: M&A Announcement
The acquisition of a U.K. hospital group division is funded offshore, debt-free, and aims to replicate operational efficiencies from previous international ventures. The deal targets margin expansion, increased private payer mix, and scalable growth in a stable, regulated market.
Narayana Hrudayalaya Slides: M&A Announcement
Narayana Hrudayalaya has posted slides in relation to its latest quarterly earnings report, which was published on November 3, 2025.
Narayana Hrudayalaya invests USD 2.5 million in Cayman Integrated Healthcare
Narayana Hrudayalaya Ltd. announced that its wholly owned overseas subsidiary, Health City Cayman Islands Ltd. (HCCI), has infused USD 2.5 million into Cayman Integrated Healthcare Ltd. (CIHL) through...
Narayana Hrudayalaya Transcript: Q1 25/26
Q1 FY 2026 featured stable hospital margins, strong ARPP growth, and expansion in Cayman and India. Integrated Care and insurance businesses are scaling but currently dilute consolidated margins, with break-even expected in coming quarters. Oncology and digital initiatives continue to drive growth.
Narayana Hrudayalaya Quarterly report: Q1 2026
Narayana Hrudayalaya has published its Q1 2026 quarterly earnings report on August 4, 2025.
Narayana Hrudayalaya Slides: Q1 2026
Narayana Hrudayalaya has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 4, 2025.
HSBC maintains reduce on Narayana Hrudayalaya, sees long gestation for India expansion
HSBC has maintained a Reduce rating on Narayana Hrudayalaya with a target price of ₹1,220, even as the company posted an operational beat in Q4FY25, mainly driven by stronger-than-expected performance...